Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND-IA TNK Part 2
NCT03340493Phase 2Completed
- Sponsor
- Neuroscience Trials Australia
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by Neuroscience Trials Australia. Started Dec 2017; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03340493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340493.